1. Home
  2. JCSE vs EDSA Comparison

JCSE vs EDSA Comparison

Compare JCSE & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JE Cleantech Holdings Limited

JCSE

JE Cleantech Holdings Limited

N/A

Current Price

$1.11

Market Cap

5.9M

ML Signal

N/A

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

N/A

Current Price

$1.50

Market Cap

12.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JCSE
EDSA
Founded
1999
2015
Country
Singapore
Canada
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
12.8M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
JCSE
EDSA
Price
$1.11
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
6.0K
32.9K
Earning Date
10-30-2025
12-12-2025
Dividend Yield
8.25%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,804,296.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$1.43
52 Week High
$1.75
$4.49

Technical Indicators

Market Signals
Indicator
JCSE
EDSA
Relative Strength Index (RSI) 45.08 33.58
Support Level $1.08 $1.43
Resistance Level $1.14 $1.54
Average True Range (ATR) 0.04 0.07
MACD -0.00 -0.01
Stochastic Oscillator 15.10 17.69

Price Performance

Historical Comparison
JCSE
EDSA

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: